Nathalie Enjolras

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding.

Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 25, 2023

Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit.

Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 12, 2023

In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study.

In vivo intranasal delivery of coagulation factor IX: a proof-of-concept study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 30, 2023

Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study.

Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 03, 2021

Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.

Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 30, 2020

Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice.

Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice.

Journal: Thrombosis and haemostasis

Published: October 30, 2019

Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.

Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 27, 2019

Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IX.

Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IX.

Journal: Thrombosis and haemostasis

Published: November 20, 2018

Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.

Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.

Journal: Haematologica

Published: February 24, 2018

Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.

Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 19, 2018

Why patients with THBD c.1611C>A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?

Why patients with THBD c.1611C>A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?

Journal: PloS one

Published: April 27, 2017

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7.

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 12, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026